Insider trade

CEO sold ~$1.25M of GILD shares in the open market

Traded Dec 29, 2025 · Filed Dec 30, 2025

Gilead SciencesGILD

~$1.25M
Reported value · 10K sh @ $124.8272: 567K
Holds after · shares reported: +18.1%
stock since the trade · S&P 500 +11.1%, $124.91 → $147.50 on Oct 1

Why it stands out

The boss of Gilead Sciences sold $1.25M of Gilead Sciences shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Dec 29, 2025
Reporting period: Not applicable
Filed with the SEC: Dec 30, 2025

CEO$1M+Pre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,248,272

Shares × reported transaction price

Timing vs results

60 days after results of Oct 30, 2025, 43 days before results of Feb 10, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $124.91 on Dec 29, 2025, within 3% of its 52-week high, little changed over the previous 30 trading days

52-week range $89.14 (Jan 8, 2025) to $128.07 (Nov 19, 2025), 92% of the way up, from 250 adjusted closes. 30 trading days earlier: $125.20 on Nov 13, 2025. Describes the past only, not a forecast

Layoff notice nearby

A WARN layoff notice covering 34 workers was filed in California on January 21, 2026.

From the official state WARN list, 23 days after the trade; 1 more notice by the company within 60 days. Shown for timing only; the two filings are separate

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+1.3%	+1.1%	+0.2%
30 days	+15.7%	+1.5%	+14.2%
90 days	+13.6%	-4.6%	+18.2%
180 days	+2.9%	+8.7%	-5.7%

Past results only. Not a forecast.

Source receipt

Record ID: 0001638643-25-000017
Filed / recorded: Dec 30, 2025, 9:23 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: GILEAD SCIENCES, INC.
Issuer CIK: 882095
Ticker: GILD
Reporting person: Daniel Patrick O'day
Relationship: Director, Officer
Officer title: Chairman & CEO
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Dec 29, 2025
Transaction code: S
Shares / units: 10,000
Price per share: $124.8272
Acquired / disposed: Disposed (D)
Shares owned after: 566,698
Ownership form: Direct
Amendment: No

Footnotes from the filing

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.
Sale prices for the transactions reported range from $124.40 to $125.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.